Short hairpin RNA-mediated down-regulation of CENP-A attenuates the aggressive phenotype of lung adenocarcinoma cells

Cellular Oncology

Volumn 37, Issue 6, 2014, Pages 399-407

  Wu, Qing ^a   Chen, Yong Feng ^b   Fu, Jie ^c   You, Qi Han ^d   Wang, Shou Mei ^e   Huang, Xue ^e   Feng, Xiao Jun ^e   Zhang, Shu Hui ^e  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

^b Maternal and Child Care Service Centre   (China)

^c SHANGHAI JIAO TONG UNIVERSITY AFFILIATED SIXTH PEOPLE S HOSPITAL   (China)

^d ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^e SHANGHAI UNIVERSITY OF TRADITIONAL CHINESE MEDICINE   (China)

Author keywords

Cell cycle regulation; Centromere protein A; Gene silencing; Lung adenocarcinoma

Indexed keywords

AUTOANTIGEN; CCNG1 PROTEIN, HUMAN; CENTROMERE PROTEIN A; CHECKPOINT KINASE 2; CHEK2 PROTEIN, HUMAN; CKS1B PROTEIN, HUMAN; CYCLIN DEPENDENT KINASE; CYCLIN DEPENDENT KINASE INHIBITOR 1B; CYCLIN G1; NONHISTONE PROTEIN; PROTEIN BAX; PROTEIN BCL 2; RHO GUANINE NUCLEOTIDE BINDING PROTEIN; S PHASE KINASE ASSOCIATED PROTEIN; SMALL INTERFERING RNA;

ADENOCARCINOMA; APOPTOSIS; CELL CYCLE CHECKPOINT; GENETICS; HUMAN; LUNG TUMOR; METABOLISM; PHYSIOLOGY; TUMOR CELL LINE;

ADENOCARCINOMA; APOPTOSIS; AUTOANTIGENS; BCL-2-ASSOCIATED X PROTEIN; CDC2-CDC28 KINASES; CELL CYCLE CHECKPOINTS; CELL LINE, TUMOR; CHECKPOINT KINASE 2; CHROMOSOMAL PROTEINS, NON-HISTONE; CYCLIN G1; CYCLIN-DEPENDENT KINASE INHIBITOR P27; HUMANS; LUNG NEOPLASMS; PROTO-ONCOGENE PROTEINS C-BCL-2; RHO GTP-BINDING PROTEINS; RNA, SMALL INTERFERING; S-PHASE KINASE-ASSOCIATED PROTEINS;

EID: 84914666152     PISSN: 22113428     EISSN: 22113436     Source Type: Journal    
DOI: 10.1007/s13402-014-0199-z     Document Type: Article

References (30)

1. A. Jemal, F. Bray, M.M. Center, J. Ferlay, E. Ward, D. Forman, Global cancer statistics. CA Cancer J. Clin. 61, 69–90 (2011)
2. A. Koren, H. Motaln, T. Cufer, Lung cancer stem cells: a biological and clinical perspective. Cell Oncol 36(4), 265–275 (2013)
3. N. Peled, M.W. Wynes, N. Ikeda, T. Ohira, K. Yoshida, J. Qian, M. Ilouze, R. Brenner, Y. Kato, C. Mascaux, F.R. Hirsch, Insulin-like growth factor-1 receptor (IGF-1R) as a biomarker for resistance to the tyrosine kinase inhibitor gefitinib in non-small cell lung cancer. Cell Oncol 36(4), 277–288 (2013)
4. R.S. Herbst, J.V. Heymach, S.M. Lippman, Lung cancer. N. Engl. J. Med. 359, 1367–1380 (2008)
5. Y. Yatabe, A.C. Borczuk, C.A. Powell, Do all lung adenocarcinomas follow a stepwise progression? Lung Cancer 74, 7–11 (2011)
6. V. De Rop, A. Padeganeh, P.S. Maddox, CENP-A: the key player behind centromere identity, propagation, and kinetochore assembly. Chromosoma 121, 527–538 (2012)
7. P. Ulivi, R. Silvestrini, Role of quantitative and qualitative characteristics of free circulating DNA in the management of patients with non-small cell lung cancer. Cell Oncol 36(6), 439–448 (2013)
8. T. Tomonaga, K. Matsushita, S. Yamaguchi, T. Oohashi, H. Shimada, T. Ochiai, K. Yoda, F. Nomura, Overexpression and mistargeting of centromere protein-A in human primary colorectal cancer. Cancer Res. 63, 3511–3516 (2003)
9. A. Amato, T. Schillaci, L. Lentini, A. Di Leonardo, CENPA overexpression promotes genome instability in pRb-depleted human cells. Mol. Cancer 8, 119 (2009)
10. E.V. Howman, K.J. Fowler, A.J. Newson, S. Redward, A.C. MacDonald, P. Kalitsis, K.H. Choo, Early disruption of centromeric chromatin organization in centromere protein A (Cenpa) null mice. Proc. Natl. Acad. Sci. U. S. A. 97, 1148–1153 (2000)
11. Y. Li, Z. Zhu, S. Zhang, D. Yu, H. Yu, L. Liu, X. Cao, L. Wang, H. Gao, M. Zhu, ShRNA-targeted centromere protein a inhibits hepatocellular carcinoma growth. PLoS One 6, e17794 (2011)
12. Q. Wu, Y.M. Qian, X.L. Zhao, S.M. Wang, X.J. Feng, X.F. Chen, S.H. Zhang, Expression and prognostic significance of centromere protein a in human lung adenocarcinoma. Lung Cancer 77, 407–414 (2012)
13. S.H. Zhang, A.M. Xu, X.F. Chen, D.H. Li, M.P. Sun, Y.J. Wang, Clinicopathologic significance of mitotic arrest defective protein 2 overexpression in hepatocellular carcinoma. Hum. Pathol. 39, 1827–1834 (2008)
14. Z. Zhu, Z. Luo, Y. Li, C. Ni, H. Li, M. Zhu, Human inhibitor of growth 1 inhibits hepatoma cell growth and influences p53 stability in a variant-dependent manner. Hepatol 49, 504–512 (2009)
15. M.W. Pfaffl, A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001)
16. X. Liu, L. Wang, S. Zhang, J. Lin, S. Zhang, M.A. Feitelson, H. Gao, M. Zhu, Mutations in the C-terminus of the X protein of hepatitis B virus regulate Wnt-5a expression in hepatoma Huh7 cells: cDNA microarray and proteomic analyses. Carcinog 29, 1207–1214 (2008)
17. T. Tuschl, Expanding small RNA interference. Nat. Biotechnol. 20, 446–448 (2002)
18. J. Bieniek, C. Childress, M.D. Swatski, W. Yang, COX-2 inhibitors arrest prostate cancer cell cycle progression by down-regulation of kinetochore/centromere proteins. Prostate 74, 999–1011 (2014)
19. J.J. Qiu, J.J. Guo, T.J. Lv, H.Y. Jin, J.X. Ding, W.W. Feng, Y. Zhang, K.Q. Hua, Prognostic value of centromere protein-A expression in patients with epithelial ovarian cancer. Tumour Biol. 34(5), 2971–5 (2013)
20. S.L. McGovern, Y. Qi, L. Pusztai, W.F. Symmans, T.A. Buchholz, Centromere protein-A, an essential centromere protein, is a prognostic marker for relapse in estrogen receptor-positive breast cancer. Breast Cancer Res. 14, R72 (2012)
21. K. Maehara, K. Takahashi, S. Saitoh, CENP-A reduction induces a p53-dependent cellular senescence response to protect cells from executing defective mitoses. Mol. Cell. Biol. 30, 2090–2104 (2010)
22. M.D. Blower, G.H. Karpen, The role of Drosophila CID in kinetochore formation, cell-cycle progression and heterochromatin interactions. Nat. Cell Biol. 3, 730–739 (2001)
23. B.E. Black, L.E. Jansen, P.S. Maddox, D.R. Foltz, A.B. Desai, J.V. Shah, D.W. Cleveland, Centromere identity maintained by nucleosomes assembled with histone H3 containing the CENP-A targeting domain. Mol. Cell 25, 309–322 (2007)
24. D.L. Bodor, L.P. Valente, J.F. Mata, B.E. Black, L.E. Jansen, Assembly in G1 phase and long-term stability are unique intrinsic features of CENP-A nucleosomes. Mol. Biol. Cell 24, 923–932 (2013)
25. T. Tsukahara, S. Kawaguchi, T. Torigoe, S. Kimura, M. Murase, S. Ichimiya, T. Wada, M. Kaya, S. Nagoya, T. Ishii, S. Tatezaki, T. Yamashita, N. Sato, Prognostic impact and immunogenicity of a novel osteosarcoma antigen, papillomavirus binding factor, in patients with osteosarcoma. Cancer Sci. 99, 368–375 (2008)
26. J.B. Old, S. Kratzat, A. Hoellein, S. Graf, J.A. Nilsson, L. Nilsson, K.I. Nakayama, C. Peschel, J.L. Cleveland, U.B. Keller, Skp2 directs Myc-mediated suppression of p27Kip1 yet has modest effects on Myc-driven lymphomagenesis. Mol. Cancer Res. 8, 353–362 (2010)
27. D. Ganoth, G. Bornstein, T.K. Ko, B. Larsen, M. Tyers, M. Pagano, A. Hershko, The cell-cycle regulatory protein Cks1 is required for SCF (Skp2)-mediated ubiquitinylation of p27. Nat. Cell Biol. 3, 321–324 (2001)
28. C.J. Sherr, J.M. Roberts, CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13, 1501–1512 (1999)
29. N.H. Chehab, A. Malikzay, M. Appel, T.D. Halazonetis, Chk2/hCds1 functions as a DNA damage checkpoint in G (1) by stabilizing p53. Genes Dev. 14, 278–288 (2000)
30. P.E. Czabotar, G. Lessene, A. Strasser, J.M. Adams, Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy. Nat. Rev. Mol. Cell Biol. 15, 49–63 (2014)